Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gynecologic 1

Conditions

Uterine Cervical Dysplasia 12Uterine Cervical Neoplasms 8Hyperthermia 2Uterine Cervical Diseases 1Squamous Intraepithelial Lesions of the Cervix 1Precancerous Conditions 1Lymphedema 1

Interventions

Biopsy 12Peripheral Blood Stem Cell Transplantation 9Cyclophosphamide 9fludarabine phosphate 8Whole-Body Irradiation 8Polymerase Chain Reaction 7Tacrolimus 6Mycophenolic Acid 6Gene Expression Profiling 6Colposcopy 6Busulfan 6Microarray Analysis 5Immunohistochemistry 5Epoetin Alfa 5Celecoxib 5Aminolevulinic Acid 5Sulindac 4Selenium 4Methotrexate 4Melphalan 4Cyclosporine 4Cetuximab 4Antilymphocyte Serum 4Vaginal Smears 3Imiquimod 3Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3Etoposide 3Eflornithine 3Darbepoetin alfa 3Comparative Genomic Hybridization 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precancerous Conditions × Conization × Clear all
NCT00003384 2015-05-29

Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer

GOG Foundation

Phase NA Completed
684 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡